Search & Analyze

Aptus Pharma Ltd.

TradingTrading

www.aptus-pharma.com BSE: 544529

₹353.55BSE

16 Sep, 4:01 PM

₹353.55

₹595 Cr

128.68

17.67

30.48%

₹353.55

₹446.80

₹80.80

Customise metrics bar

Price Performance

Peer Comparison

Name
ADANI ENTER ADANIENT	2,924.10	39.76	3,95,842.03	0.04	-890.34	-280.29%	5,953.89	1.30%	24.62
AEGISLOG AEGISLOG	1,381.20	36.62	48,480.12	0.66	394.15	469.75%	1,068.73	27.75%	34.89
CPPLUS CPPLUS	3,555.00	96.12	42,055.80	0.04	140.89	353.03%	1,398.59	91.36%	31.52
PREMIERENE PREMIERENE	899.00	289.78	40,810.24	0.11	28.69	22.30%	176.36	-5.68%	10.13
REDINGTON REDINGTON	387.35	21.67	30,282.03	1.59	321.01	60.34%	20,753.20	62.68%	26.87
HONASA HONASA	471.35	63.46	15,367.15	0.66	84.31	111.30%	696.32	19.31%	19.87
LLOYDSENT LLOYDSENT	66.70	208.93	10,182.10	0.22	2.44	-98.90%	43.11	-56.19%	6.50
Aptus Pharma Ltd.	353.55	128.68	594.50	0.00					30.01

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00
INCOME :
	14.07	17.97	24.94	47.83
	13.90	17.86	24.56	46.57
EXPENDITURE :
Increase/Decrease in Stock	-0.90	-1.13	-3.63	-6.51
Raw Material Consumed	5.67	7.95	12.67	27.88
Power & Fuel Cost	0.00	0.01	0.00	0.01
Employee Cost	1.58	2.31	3.57	5.21
Other Manufacturing Expenses	0.15	0.14	0.62	1.48
General and Administration Expenses	1.50	2.22	1.58	2.10
Selling and Distribution Expenses	4.91	4.68	4.25	8.41
Miscellaneous Expenses	0.38	0.13	0.65	0.55
	13.28	16.31	19.71	39.12
Operating Profit (Excl OI)	0.62	1.55	4.85	7.45
		0.03	0.08	0.13
	0.62	1.57	4.93	7.59
Interest	0.14	0.24	0.47	0.81
PBDT	0.48	1.33	4.46	6.78
	0.18	0.21	0.27	0.41
Profit Before Taxation & Exceptional Items	0.30	1.12	4.20	6.37
	0.30	1.12	4.20	6.37
Provision for Tax	0.10	0.32	1.10	1.75
	0.19	0.80	3.10	4.62
Extra items	0.00	0.00	0.00	0.00
Consolidated Net Profit	0.19	0.80	3.10	4.62
Profit Balance B/F	0.20	0.32	1.12	1.17
Appropriations	0.40	1.12	4.22	5.79
	6.48	26.60	6.20	6.73
Adjusted EPS	0.52	2.13	0.50	2.69

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	0.30	0.30	5.00	6.86
Total Reserves	0.67	1.47	1.97	16.49
Reserve excluding Revaluation Reserve	0.67	1.47	1.97	16.49
Revaluation reserve	0.00	0.00	0.00	0.00
	0.97	1.77	6.97	23.35
Secured Loans	0.00
Unsecured Loans	2.01	3.96	2.62	0.52
Deferred Tax Assets / Liabilities	-0.04	-0.06	-0.07	-0.09
Long Term Provisions	0.11	0.17	0.25	0.36
Total Non-Current Liabilities	2.08	4.07	2.80	0.79
Trade Payables	1.36	1.35	1.31	8.15
Other Current Liabilities	1.63	1.43	2.97	2.95
Short Term Borrowings		0.99	6.64	6.45
Short Term Provisions	0.14	0.36	1.17	1.76
Total Current Liabilities	3.13	4.14	12.08	19.31
Total Liabilities	6.18	9.97	21.85	43.44
Gross Block	0.91	1.24	1.86	4.04
Less: Accumulated Depreciation	0.39	0.60	0.87	1.28
Net Block	0.52	0.63	0.99	2.77
Long Term Investment	0.00	0.00	0.00	0.00
Long Term Loans & Advances	0.01	0.01	0.05	0.05
Other Non Current Assets	0.00	1.01	1.07	5.39
Total Non-Current Assets	0.53	1.65	2.11	8.21
Inventories	2.30	3.43	7.06	13.57
Sundry Debtors	2.40	3.35	5.64	18.76
Cash and Bank	0.54	0.91	5.21	1.03
Other Current Assets	0.02	0.04	0.55	0.53
Short Term Loans and Advances	0.40	0.59	1.27	1.35
Total Current Assets	5.65	8.32	19.74	35.24
Net Current Assets (Including Current Investments)	2.52	4.19	7.65	15.93
Total Assets	6.18	9.97	21.85	43.44
Total Debt	2.21	5.31	10.36	7.18
	32.28	58.88	13.93	34.03
Adjusted Book Value	6.46	11.78	1.11	13.61

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00
	0.30	1.12	4.20	6.37
Adjustment	0.32	0.43	0.65	1.07
Changes In working Capital	-0.68	-3.38	-5.57	-11.86
Cash Flow after changes in Working Capital	-0.06	-1.84	-0.72	-4.41
Cash Flow from Operating Activities	-0.18	-2.17	-1.84	-5.60
Cash Flow from Investing Activities	-0.35	-0.30	-0.54	-6.37
Cash Flow from Financing Activitie	0.81	2.86	6.68	7.79
Net Cash Inflow / Outflow	0.28	0.38	4.30	-4.19
Opening Cash & Cash Equivalents	0.26	0.54	0.91	5.21
Closing Cash & Cash Equivalent	0.54	0.91	5.21	1.03

Ratios

Valuation

128.68

17.67

79.16

12.76

2.69

19.61

Profitability

30.48

30.01

14.15

15.58

9.66

Leverage & Liquidity

0.31

1.83

8.92

Returns

0.00

1.47

Shareholding Pattern

Numbers in percentages

Particulars	Sep '25	Dec '25	Mar '26	Jun '26
	72.89	72.89	72.89	72.89
	12.83	0.00	0.00	0.00
	14.29	27.11	27.11	27.11
	27.11	27.11	27.11	27.11
No. of Shareholders	213	302	337	686

Corporate Actions

Showing: All

Date	Type	Details
2026-08-21	AGM
2026-08-12	Board Meeting	A.G.M.
2026-08-05	Board Meeting	Preferential Issue of shares

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

TradingTrading

Aptus Pharma Ltd. operates in the Trading sector under the Trading industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

8 members across the board and senior leadership

Tejash Maheshchandra Hathi

Managing Director

—

Chetan Shantilal Lalseta

Non Executive Director

—

Riddhish Natwarlal Tanna

Non Executive Director

—

Jyotiben Hasmukhbhai Chandarana

Non Executive Director

—

Vikas Rambhai Jobanputra

Non Executive Independent Director

—

Sejal Harit Palan

Non Executive Independent Director

—

Mohini Gandhi

Company Secretary & Compliance Officer

—

Mohini Hardikbhai Gandhi

Company Secretary & Compliance Officer

—

Latest News

News

4 of 4 articles

EQUITY14 May 2026 · 10:46

Aptus Pharma informs about updates

EQUITY14 May 2026 · 10:35

Aptus Pharma informs about disclosure

EQUITY14 May 2026 · 10:33

Aptus Pharma informs about updates on SAST

EQUITY14 May 2026 · 09:46

Aptus Pharma informs about disclosure

₹353.55

+0%